Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis（UPRISE）

Clinical trial NCT07550673 · RECRUITING

Trial details

NCT number: NCT07550673
Sponsor: Xijing Hospital of Digestive Diseases
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Severe Ulcerative Colitis

Start date: 2026-04-20
Primary completion: 2028-04-01
Enrollment: 226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.